Skip to content

Clinical trials

Osteoarthritis trials with no applicable phase and unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Osteoarthritis Phase: Not applicable Status: Unknown status Clear all

160 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20031
20052
20072
20082
20092
20103
20114
20125
20137
20147
20157
201616
20179
201810
201917
202012
202116
202213
202316
20244

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status160

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The Catholic University of Korea9
University of Sao Paulo General Hospital5
Fondazione Don Carlo Gnocchi ETS3
Ottawa Hospital Research Institute3
Assaf-Harofeh Medical Center2
Cairo University2
Centre of Postgraduate Medical Education2
Chang Gung Memorial Hospital2
Federal State Budgetary Scientific Institution, Research Institute of Fundamental and Clinical Immunology2
Herlev and Gentofte Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Osteoarthritis160
Osteoarthritis, Knee45
Pain13
Arthritis11
Joint Diseases7
Arthritis, Rheumatoid4
Musculoskeletal Diseases4
Osteoarthritis, Hip4
Osteonecrosis4
Anxiety Disorders3

Trials

Showing 1 to 25 of 160. Each trial links to its page on Pharma Observatory.

60 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.